跳至主要内容
临床试验/NL-OMON31647
NL-OMON31647已完成不适用

Study On The Effectiveness Of Oral Administration Of Prolyl Endoprotease For Gluten Detoxification As A Means To Treat Coeliac Disease - AN-PEP supportive treatment in coeliac disease

DSM Food Specialties0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Confirmed diagnosis of coeliac disease (Marsh III B/C)
  • * Detectable coeliac disease specific antibodies (EMA, tTGA) at time of diagnosis.
  • * A strict gluten free diet for at least 1 year and normalised villous architecture (Marsh 0/I);
  • * Male and female, 18-70 years old;
  • * No detectable anti-endomysium and low anti-tissue transglutaminase (< 4 U/ml) prior to the start of the study;
  • * Patient is willing to undergo all protocol related assessments and visits (including up to 3 separate oesophago-gastro-duodenoscopies with multiple biopsies taken each time) from the duodenum descendents;
  • * Patient has read the information provided on the study and given written consent;
  • * Female participants at fertile age must use adequate contraception.

排除标准

  • * Use of any immunoregulatory drug within the last 6 months;
  • * Use of any anticoagulant drug;
  • * Clinically suspected bleeding tendency;
  • * Pregnancy or breast feeding;
  • * Presence of any concurrent active infection;
  • * IgA deficiency.

研究者

相似试验